Literature DB >> 33530560

USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.

Hiroshi Kitamura1, Mayuko Hashimoto1.   

Abstract

Ubiquitin specific protease (USP) 2 is a multifunctional deubiquitinating enzyme. USP2 modulates cell cycle progression, and therefore carcinogenesis, via the deubiquitination of cyclins and Aurora-A. Other tumorigenic molecules, including epidermal growth factor and fatty acid synthase, are also targets for USP2. USP2 additionally prevents p53 signaling. On the other hand, USP2 functions as a key component of the CLOCK/BMAL1 complex and participates in rhythmic gene expression in the suprachiasmatic nucleus and liver. USP2 variants influence energy metabolism by controlling hepatic gluconeogenesis, hepatic cholesterol uptake, adipose tissue inflammation, and subsequent systemic insulin sensitivity. USP2 also has the potential to promote surface expression of ion channels in renal and intestinal epithelial cells. In addition to modifying the production of cytokines in immune cells, USP2 also modulates the signaling molecules that are involved in cytokine signaling in the target cells. Usp2 knockout mice exhibit changes in locomotion and male fertility, which suggest roles for USP2 in the central nervous system and male genital tract, respectively. In this review, we summarize the cellular events with USP2 contributions and list the signaling molecules that are upstream or downstream of USP2. Additionally, we describe phenotypic differences found in the in vitro and in vivo experimental models.

Entities:  

Keywords:  brain; cell cycle; circadian clock; deubiquitination; fertility; inflammation; ion balance; metabolic disorder; tumorigenesis; ubiquitin-specific protease

Mesh:

Substances:

Year:  2021        PMID: 33530560      PMCID: PMC7865608          DOI: 10.3390/ijms22031209

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  181 in total

1.  Divergent N-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures.

Authors:  H Lin; A Keriel; C R Morales; N Bedard; Q Zhao; P Hingamp; S Lefrançois; L Combaret; S S Wing
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 2.  TNF receptor signalling in autoinflammatory diseases.

Authors:  Heledd H Jarosz-Griffiths; Jonathan Holbrook; Samuel Lara-Reyna; Michael F McDermott
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

3.  Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia.

Authors:  Jason W Mastaitis; Elisa Wurmbach; Hui Cheng; Stuart C Sealfon; Charles V Mobbs
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

4.  Usp2-69 overexpression slows down the progression of rat anti-Thy1.1 nephritis.

Authors:  Xing Mao; Weili Luo; Jianyong Sun; Nianji Yang; Linda Wei Zhang; Zhonghua Zhao; Zhigang Zhang; Huijuan Wu
Journal:  Exp Mol Pathol       Date:  2016-09-15       Impact factor: 3.362

Review 5.  Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy.

Authors:  N Govindarajah; R Clifford; D Bowden; P A Sutton; J L Parsons; D Vimalachandran
Journal:  Crit Rev Oncol Hematol       Date:  2019-04-13       Impact factor: 6.312

6.  Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.

Authors:  Mohammad Reza Boustani; Reza Jalili Khoshnood; Fermoozan Nikpasand; Zabihollah Taleshi; Koorosh Ahmadi; Emad Yahaghi; Peyman Karimi Goudarzi
Journal:  J Neurol Sci       Date:  2016-03-02       Impact factor: 3.181

Review 7.  Novel concepts in insulin regulation of hepatic gluconeogenesis.

Authors:  Andreas Barthel; Dieter Schmoll
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-10       Impact factor: 4.310

Review 8.  A review on the biology and properties of adipose tissue macrophages involved in adipose tissue physiological and pathophysiological processes.

Authors:  Yunjia Li; Ke Yun; Runqing Mu
Journal:  Lipids Health Dis       Date:  2020-07-09       Impact factor: 3.876

Review 9.  Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis.

Authors:  Hsiao-Chen Chiu; Chia-Jung Li; Giou-Teng Yiang; Andy Po-Yi Tsai; Meng-Yu Wu
Journal:  J Clin Med       Date:  2019-03-30       Impact factor: 4.241

Review 10.  Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.

Authors:  Maria Luisa Calabrò; Nayana Lazzari; Giulia Rigotto; Marco Tonello; Antonio Sommariva
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

View more
  4 in total

1.  Dysregulation and activities of ubiquitin specific peptidase 2b in the pathogenesis of hepatocellular carcinoma.

Authors:  Christina Nadolny; Xinmu Zhang; Qiwen Chen; Syed F Hashmi; Winifer Ali; Christopher Hemme; Nagib Ahsan; Yuan Chen; Ruitang Deng
Journal:  Am J Cancer Res       Date:  2021-10-15       Impact factor: 6.166

2.  Ubiquitin-Specific Protease 2 in the Ventromedial Hypothalamus Modifies Blood Glucose Levels by Controlling Sympathetic Nervous Activation.

Authors:  Mayuko Hashimoto; Masaki Fujimoto; Kohtarou Konno; Ming-Liang Lee; Yui Yamada; Koya Yamashita; Chitoku Toda; Michio Tomura; Masahiko Watanabe; Osamu Inanami; Hiroshi Kitamura
Journal:  J Neurosci       Date:  2022-05-03       Impact factor: 6.709

Review 3.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

4.  Integrative bioinformatics analysis to identify the effects of circadian rhythm on Crohn's disease.

Authors:  Dan Liu; Yin-Yun Chen; Qing-Qing Li; Ming Xu; Jiang-Tao Liao; Ben Wang
Journal:  Front Mol Biosci       Date:  2022-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.